{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:53:36Z","timestamp":1777607616917,"version":"3.51.4"},"reference-count":54,"publisher":"American Psychological Association (APA)","issue":"1","funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"DOI":"10.1037\/1064-1297.15.1.81","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T13:47:08Z","timestamp":1171288028000},"page":"81-92","source":"Crossref","is-referenced-by-count":36,"title":["High-dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal, urges, smoking, and effects of smoking."],"prefix":"10.1037","volume":"15","author":[{"given":"Damaris J.","family":"Rohsenow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent E.","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Swift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selene V.","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D.","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary B.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"15","published-online":{"date-parts":[[2007]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Balfour, D. J. K. (1994). Neural mechanisms underlying nicotine dependence. Addiction, 89, 1419\u20131423.","DOI":"10.1111\/j.1360-0443.1994.tb03738.x"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Brauer, L. H., Behm, F. M., Westman, E. C., Patel, P., & Rose, J. E. (1999). Naltrexone blockade of nicotine effects in cigarette smokers. Psychopharmacology, 143, 339\u2013346.","DOI":"10.1007\/s002130050957"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Cepeda-Benito, A., Reynoso, J. T., & Erath, S. (2004). Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology, 72, 712\u2013722.","DOI":"10.1037\/0022-006X.72.4.712"},{"key":"E00004","unstructured":"Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum."},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155\u2013159.","DOI":"10.1037\/0033-2909.112.1.155"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Covey, L. S., Glassman, A. G., & Stetner, F. (1999). Naltrexone effects on short-term and long-term smoking cessation. Journal of Addictive Disorders, 18, 31\u201340.","DOI":"10.1300\/J069v18n01_04"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, 7\u201316.","DOI":"10.1080\/14622200020032051"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Dale, L. C., Hurt, R. D., Offord, K. P., Lawson, G. M., Croghan, I. T., & Schroeder, D. R. (1995). High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. Journal of the American Medical Association, 274, 1353\u20131358.","DOI":"10.1001\/jama.1995.03530170033028"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Del Boca, F. K., Kranzler, H. R., Brown, J., & Korner, P. F. (1996). Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcoholism, Clinical and Experimental Research, 20, 1412\u20131417.","DOI":"10.1111\/j.1530-0277.1996.tb01142.x"},{"key":"E00010","unstructured":"Epstein, A. M., & King, A.C. (2003, February). Naltrexone attenuates behavioral and objective measures of cigarette smoking. Paper presented at the 9th annual meeting of the Society for Research on Nicotine and Tobacco, New Orleans, Louisiana."},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Garvey, A. J., Bliss, R. E., Hitchcock, J. L., Heinold, J. W., & Rosner, B. (1992). Predictors of smoking relapse among self-quitters: A report from the Normative Aging Study. Addictive Behaviors, 17, 367\u2013377.","DOI":"10.1016\/0306-4603(92)90042-T"},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Gorelick, D. A., Rose, J., & Jarvik, M. E. (1989). Effect of naloxone on cigarette smoking. Journal of Substance Abuse, 1, 153\u2013159.","DOI":"10.1016\/S0899-3289(88)80018-X"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Havermans, R. C., Debaere, S., Smulders, F. T. Y., Wiers, R. W., & Jansen, A. T. M. (2003). Effect of cue exposure, urge to smoke and nicotine deprivation on cognitive performance in smokers. Psychology of Addictive Behaviors, 17, 336\u2013339.","DOI":"10.1037\/0893-164X.17.4.336"},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstr\u00f6m, K. O. (1991). The Fagerstr\u00f6m Test for Nicotine Dependence: A revision of the Fagerstr\u00f6m Tolerance Questionnaire. British Journal of Addiction, 86, 1119\u20131127.","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"E00015","unstructured":"Houtsmuller, E. J., Clemmey, P. A., Sigler, L. A., & Stitzer, M. L. (1997). Effects of naltrexone on smoking and abstinence. In L. S.Harris (Ed.), Problems of drug dependence 1996: Proceedings of the 58th Annual Scientific Meeting(NIDA Research Monograph No. 174, p. 68). Rockville, MD: National Institute of Drug Abuse."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Hughes, J. R., Gulliver, S. B., Fenwick, J. W., Cruiser, K., Vallierere, W. A., Pepper, S., et al. (1992). Smoking cessation among self-quitters. Health Psychology, 11, 331\u2013334.","DOI":"10.1037\/0278-6133.11.5.331"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289\u2013294.","DOI":"10.1001\/archpsyc.1986.01800030107013"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"Hughes, J., & Hatsukami, D. K. (1998). Errors in using tobacco withdrawal scale. Tobacco Control, 7, 92\u201393.","DOI":"10.1136\/tc.7.1.92a"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Hughes, J. R., Lesmes, G. R., Hatsukami, D. K., Richmond, R. L., Lichtenstein, E., Jorenby, D. E., et al. (1999). Are higher doses of nicotine replacement more effective for smoking cessation?Nicotine & Tobacco Research, 1, 169\u2013174.","DOI":"10.1080\/14622299050011281"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Hurt, R. D., Dale, L. C., Offord, K. P., & Croghan, I. T. (1995). Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction, 90, 1541\u20131546.","DOI":"10.1111\/j.1360-0443.1995.tb02816.x"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Hurt, R. D., Krook, J. E., Croghan, I. T., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., et al. (2003). Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. Journal of Clinical Oncology, 21, 914\u2013920.","DOI":"10.1200\/JCO.2003.08.160"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Hutchison, K. E., Monti, P. M., Rohsenow, D. J., Swift, R., Colby, S. M., Gnys, M., et al. (1999). Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology, 142, 139\u2013143.","DOI":"10.1007\/s002130050872"},{"key":"E00023","unstructured":"Jennings, J. R. (1983). Attention and coronary artery disease. In D. S.Krantz, A.Baum, & J.Singer (Eds.), Advances in behavioral medicine: Cardiovascular disorders (pp. 85\u2013124). Hillsdale, NJ: Erlbaum."},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Jorenby, D. E., Hatsukami, D. K., Smith, S. S., Fiore, M. C., Allen, S., Jensen, J., & Baker, T. B. (1996). Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain. Psychopharmacology, 128, 130\u2013138.","DOI":"10.1007\/s002130050118"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Jorenby, D. E., Smith, S. S., Fiore, M. C., Hurt, R. D., Offord, K. P., Croghan, I. T., et al. (1995). Varying nicotine patch dose and type of smoking cessation counseling. Journal of the American Medical Association, 274, 1347\u20131352.","DOI":"10.1001\/jama.1995.03530170027027"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Kalivas, P. W., & Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Research Review, 16, 223\u2013244.","DOI":"10.1016\/0165-0173(91)90007-U"},{"key":"E00027","doi-asserted-by":"crossref","unstructured":"Karras, A., & Kane, J. (1980). Naloxone reduces cigarette smoking. Life Science, 27, 1541\u20131545.","DOI":"10.1016\/0024-3205(80)90562-7"},{"key":"E00028","unstructured":"King, A., Chilton, E., Hatsukami, D., & Niaura, R. (2003, February). Efficacy of naltrexone in smoking cessation: Effects of gender on clinical response. Paper presented at the 9th annual meeting of the Society for Research on Nicotine and Tobacco, New Orleans, Louisiana."},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"King, A. C., & Meyer, P. J. (2000). Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacology, Biochemistry, and Behavior, 66, 563\u2013572.","DOI":"10.1016\/S0091-3057(00)00258-6"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Kozlowski, L. T., Mann, R. E., Wilkinson, D. A., & Poulos, C. X. (1989). \u201cCravings\u201d are ambiguous: Ask about urges or desires. Addictive Behaviors, 14, 443\u2013445.","DOI":"10.1016\/0306-4603(89)90031-2"},{"key":"E00031","doi-asserted-by":"crossref","unstructured":"Krishnan-Sarin, S., Meandzija, B., & O'Malley, S. (2003). Naltrexone and nicotine patch in smoking cessation: A preliminary study. Nicotine & Tobacco Research, 5, 851\u2013857.","DOI":"10.1080\/14622200310001614601"},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Krishnan-Sarin, S., Rosen, M. I., & O'Malley, S. (1999). Naloxone challenge in smokers: Preliminary evidence of an opioid component in nicotine dependence. Archives of General Psychiatry, 56, 663\u2013668.","DOI":"10.1001\/archpsyc.56.7.663"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Levin, E. D., Westman, E. C., Stein, R. M., Carnahan, E., Sanchez, M., Herman, S., et al. (1994). Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. Journal of Clinical Psychopharmacology, 14, 41\u201349.","DOI":"10.1097\/00004714-199402000-00006"},{"key":"E00034","unstructured":"Mason, B. J. (2005, June). Naltrexone and Nicotrol for concurrent tobacco and alcohol dependence. In Rohsenow, D. J., & Fertig, J. (Chairs), Smoking and alcohol abuse: From lab to clinic. Satellite symposium conducted at the annual meeting of the Research Society on Alcoholism, Santa Barbara, CA."},{"key":"E00035","unstructured":"Mason, B. J., Williams, L. D., Salvato, F. R., Mestre, S., & Culter, R. B. (2004). Naltrexone treatment for concurrent tobacco and alcohol dependence. Alcoholism, Clinical and Experimental Research, 28, 114A."},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Nemeth-Coslett, R., & Griffiths, R. R. (1986). Naloxone does not affect cigarette smoking. Psychopharmacology, 89, 261\u2013264.","DOI":"10.1007\/BF00174355"},{"key":"E00037","unstructured":"Niaura, R. S., Hitsman, B., Abrams, D. B., Rohsenow, D. J., & Monti, P. M. (2003). Validation and replication of the Nicotine Effects Questionnaire. Nicotine & Tobacco Research, 5, 788."},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Perkins, K. A., Gerlach, D., Wilson, A., Broge, M., & Fonte, C. (2001). Reinforcing effects of nicotine as a function of smoking status. Experimental and Clinical Psychopharmacology, 9, 243\u2013250.","DOI":"10.1037\/1064-1297.9.3.243"},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Pickens, R. W., & Johanson, C. E. (1992). Craving: Consensus of status and agenda for future research. Drug and Alcohol Dependence, 30, 127\u2013131.","DOI":"10.1016\/0376-8716(92)90017-7"},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Review, 18, 247\u2013291.","DOI":"10.1016\/0165-0173(93)90013-P"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Rohsenow, D. J. (1982). Control over interpersonal evaluation and alcohol consumption in male social drinkers. Addictive Behaviors, 7, 113\u2013121.","DOI":"10.1016\/0306-4603(82)90036-3"},{"key":"E00042","doi-asserted-by":"crossref","unstructured":"Rohsenow, D. J., Monti, P. M., Colby, S. M., Gulliver, S. B., Swift, R. M., & Abrams, D. B. (2003). Naltrexone treatment for alcoholics: Effect on cigarette smoking rates. Nicotine & Tobacco Research, 5, 231\u2013236.","DOI":"10.1080\/1462220031000073298"},{"key":"E00043","unstructured":"Rohsenow, D. J., & Niaura, R. S. (1999). Comments on \u201cMeta-analysis of cue reactivity in addiction research\u201d: Reflections on the state of cue reactivity theories and research. Addiction, 94, 343\u2013344."},{"key":"E00044","doi-asserted-by":"crossref","unstructured":"Sayette, M. A., & Hufford, M. R. (1994). Effects of cue exposure and deprivation on cognitive resources in smokers. Journal of Abnormal Psychology, 103, 812\u2013818.","DOI":"10.1037\/0021-843X.103.4.812"},{"key":"E00045","doi-asserted-by":"crossref","unstructured":"Shiffman, S. (1982). Relapse following smoking cessation: A situational analysis. Journal of Consulting and Clinical Psychology, 50, 71\u201386.","DOI":"10.1037\/0022-006X.50.1.71"},{"key":"E00046","doi-asserted-by":"crossref","unstructured":"Shiffman, S., Sweeney, C. T., & Dresler, C. M. (2005). Nicotine patch and lozenge are effective for women. Nicotine & Tobacco Research, 7, 119\u2013127.","DOI":"10.1080\/14622200412331328439"},{"key":"E00047","doi-asserted-by":"crossref","unstructured":"Sutherland, G., Stapleton, J. A., Russell, M. A. H., & Feyerband, G. (1995). Naltrexone, smoking behavior and cigarette withdrawal. Psychopharmacology, 120, 418\u2013425.","DOI":"10.1007\/BF02245813"},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Teneggi, V., Tiffany, S. T., Squassante, L., Milleri, S., Ziviani, L., & Bye, A. (2002). Smokers deprived of cigarettes for 72 hours: Effect of nicotine patches on craving and withdrawal. Psychopharmacology, 164, 177\u2013187.","DOI":"10.1007\/s00213-002-1176-1"},{"key":"E00049","doi-asserted-by":"crossref","unstructured":"Tidey, J. W., Rohsenow, D. J., Kaplan, G. K., & Swift, R. M. (2005). Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine & Tobacco Research, 7, 421\u2013429.","DOI":"10.1080\/14622200500125724"},{"key":"E00050","doi-asserted-by":"crossref","unstructured":"Tiffany, S. T., Cox, L. S., & Elash, C. A. (2000). Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. Journal of Consulting and Clinical Psychology, 68, 233\u2013240.","DOI":"10.1037\/0022-006X.68.2.233"},{"key":"E00051","unstructured":"U.S. Department of Health and Human Services. (2000). Treating Tobacco Use and Dependence: Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service."},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Wise, R. A. (1988). The neurobiology of craving: Implications for the understanding and treatment of addiction. Journal of Abnormal Psychology, 97, 118\u2013132.","DOI":"10.1037\/0021-843X.97.2.118"},{"key":"E00053","doi-asserted-by":"crossref","unstructured":"Wong, G. Y., Wolter, T. D., Croghan, G. A., Croghan, I. T., Offord, K. P., & Hurt, R. D. (1999). A randomized trial of naltrexone for smoking cessation. Addiction, 94, 1227\u20131237.","DOI":"10.1046\/j.1360-0443.1999.948122713.x"},{"key":"E00054","doi-asserted-by":"crossref","unstructured":"Yudkin, P., Munafo, M., Hey, K., Roberts, S., Welch, S., Johnstone, E., et al. (2004). Effectiveness of nicotine patches in relation to genotype in women versus men: Randomized controlled trial. British Medical Journal, 328, 989\u2013990.","DOI":"10.1136\/bmj.38050.674826"}],"container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psycnet.apa.org\/journals\/pha\/15\/1\/81.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T19:53:45Z","timestamp":1707162825000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.apa.org\/doi\/10.1037\/1064-1297.15.1.81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007]]}},"alternative-id":["2007-01684-007","17295587"],"URL":"https:\/\/doi.org\/10.1037\/1064-1297.15.1.81","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1071125.524123","asserted-by":"object"}]},"ISSN":["1936-2293","1064-1297"],"issn-type":[{"value":"1936-2293","type":"electronic"},{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}